Dulaglutide [Trulicity], a glucagon-like peptide-1 (GLP-1) receptor agonist, approved for the treatment of type 2 diabetes

Last Updated on September 20, 2014 by Joseph Gut – thasso

September 18, 2014 – We learn today from the U.S. Food and Drug Administration (FDA) of the approval of  Trulicity (dulaglutide), a once-weekly subcutaneous injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes. Type 2 diabetes affects about 26 million people and accounts for more than 90 percent of diabetes cases diagnosed in the United States. Over time, high blood sugar levels can increase the risk for serious complications, including heart disease, blindness, and nerve and kidney damage.

Diabetes“Type 2 diabetes is a serious chronic condition that causes blood glucose levels to rise higher than normal,” said Mary Parks, M.D., deputy director of the Office of Drug Evaluation II in the FDA’s Center for Drug Evaluation and Research. “Trulicity is a new treatment option, which can be used alone or added to existing treatment regimens to control blood sugar levels in the overall management of type 2 diabetes.”

Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist (also known as incretin mimetics). GLP-1 is a hormone that helps normalize blood sugar levels. The drug’s safety and effectiveness were evaluated in six clinical trials in which 3,342 patients with type 2 diabetes received Trulicity. Patients receiving Trulicity had an improvement in their blood sugar control as observed with reductions in HbA1c level (hemoglobin A1c is a measure of blood sugar control).  Trulicity has been studied as a stand-alone therapy and in combination with other type 2 diabetes therapies, including metformin, sulfonylurea, thiazolidinedione, and prandial insulin. Trulicity should not be used to treat people with type 1 diabetes; those who have increased ketones in their blood or urine (diabetic ketoacidosis); those with severe stomach or intestinal problems; or as first-line therapy for patients who cannot be managed with diet and exercise.

Trulicity has a boxed warning that tumors of the thyroid gland (thyroid C-cell tumors) have been observed in rodent studies with Trulicity but that it is unknown whether Trulicity causes thyroid C-cell tumors, including a type of thyroid cancer called medullary thyroid carcinoma (MTC), in humans. Trulicity should not be used in patients with a personal or family history of MTC or in patients with multiple endocrine neoplasia syndrome type 2 (a disease in which patients have tumors in more than one gland in their body, which predisposes them to MTC). In clinical trials, the most common side effects observed in patients treated with Trulicity were nausea, diarrhea, vomiting, abdominal pain, and decreased appetite.

The FDA is requiring the following post-marketing studies for Trulicity:

  • a clinical trial to evaluate dosing, efficacy, and safety in pediatric patients;
  • a study to assess potential effects on sexual maturation, reproduction, and CNS development and function in immature rats;
  • a medullary thyroid carcinoma (MTC) case registry of at least 15 years duration to identify any increase in MTC incidence related to Trulicity;
  • a clinical trial comparing Trulicity with insulin glargine on glycemic control in patients with type 2 diabetes and moderate or severe renal impairment; and
  • a cardiovascular outcomes trial to evaluate the cardiovascular risk of Trulicity in patients with high baseline risk of cardiovascular disease.

The FDA approved Trulicity with a Risk Evaluation and Mitigation Strategy (REMS), which consists of a communication plan to inform health care professionals about the serious risks associated with Trulicity.

Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

19 Comments on “Dulaglutide [Trulicity], a glucagon-like peptide-1 (GLP-1) receptor agonist, approved for the treatment of type 2 diabetes

  1. This is the perfect webpage for everyone who hopes to understand this topic.

    You understand so much its almost tough to argue with you (not that I actually would
    want to…HaHa). You definitely put a brand new spin on a subject
    that has been discussed for a long time. Great stuff, just wonderful!

  2. Greetings from Ohio! I’m bored to tears at work so I decided to browse your website on my iphone during lunch break.
    I enjoy the info you present here and can’t wait to take a look when I get home.
    I’m shocked at how fast your blog loaded on my cell phone ..

    I’m not even using WIFI, just 3G .. Anyhow, amazing blog!

    • Hi. Happy to hear that even on the smartphone, you can get thasso.com in an acceptable manner. If at any time you would have propositions for improvements, please let me know. Because we are a very intercultural approach, sometimes obvious things may get lost or are not considered. So, please, any feedback is welcome. On technical terms, on content terms, or on terms that are more of personal. such as disease. We are open…

  3. [url=http://www.muvpilates.com.br/img/new.php?k=2809-Dianabol-Ebay-Anadrol-300-Dianabol-Oral-Steroid-Side-Effects.html]Dianabol Ebay[/url]
    Know what you will be functioning toward as soon as your are becoming into network marketing. Know what your targets are, and how you plan on reaching them. You are getting relied upon to assist a current business develop. When you find yourself profitable around this you can then increase your own private organization.
    [url=http://crm.tuvakademia.onliner.hu/includes/new.php?k=3548-Equipoise-Blood-Work-Anavar-Reddit-Buy-Boldenone-India.html]Equipoise Blood Work[/url]
    Do you know that when producing advertising for mobile phones, you should guarantee that it fits web browser compatibility specifications of multiple types, rather than the only one or two which you would look at for pc dependent content material? If the appeal to your interest, you then will enjoy the rest of the mobile phone advertising suggest that is supplied listed below.
    [url=http://www.metalicahome.com.br/images/file.php?by=1813-Oral-Steroids-Bodybuilding-Side-Effects-Methenolone-Enanthate-First-Cycle-Oral-Turinabol-20/]Oral Steroids Bodybuilding Side Effects[/url]
    If you need to shut off your plumbing related system for routine maintenance, complete several buckets water in order to continue to flush your bathroom. Fill up the pan by using a whole pail to flush it. This may prevent your toilet from clogging if you want to sustain your plumbing related program.
    [url=http://www.syltrans.com.br/admin/box.asp?m=433-Testosterone-Cypionate-Thailand,Boldenone-Undecylenate-250mg,Mesterolone-For-Sale]Testosterone Cypionate Thailand[/url]

  4. I think what you posted made a great deal of sense.
    But, what about this? suppose you were to create
    a awesome headline? I am not suggesting your content isn’t good.,
    but suppose you added a headline that makes people
    desire more? I mean Dulaglutide [Trulicity] approved for
    type 2 diabetes | thasso is a little vanilla. You might look at Yahoo’s front page and
    see how they create article headlines to get people to
    click. You might add a video or a related picture or two to get readers interested about what you’ve written. Just my opinion, it could bring your
    website a little livelier.

    • Thanks for your comment. I know, we could be flashier in headlines. On the other hand, headlines and “bling bling” do not really help patients in need of serious, profound, and applicable information that helps ease sometimes very serious conditions. Some patients (and readers) prefer the to the point titles of posts. So, we may have to find the balance…….

  5. What’s up everyone, it’s my first pay a visit at this web site, and article
    is in fact fruitful designed for me, keep up posting these types of
    articles or reviews.

  6. With havin so much written content do you ever run into any
    issues of plagorism or copyright violation? My site has a lot of completely unique content I’ve either written myself or outsourced but it looks like a lot of it
    is popping it up all over the web without my agreement.
    Do you know any techniques to help stop content from being ripped off?

    I’d truly appreciate it.

  7. Excellent blog here! Also your web site loads up very fast!
    What web host are you using? Can I get your affiliate link to
    your host? I wish my site loaded up as fast as yours lol

  8. Hey there I am so excited I found your blog page, I really found you by error, while I was researching on Yahoo for something else, Regardless I am here now and would just like to say kudos for a tremendous post and a all round interesting blog (I also love the theme/design), I donít have time to browse it all at the minute but I have bookmarked it and also added in your RSS feeds, so when I have time I will be back to read more, Please do keep up the excellent job.

  9. Hello I am so excited I found your weblog, I really found you by error, while I was
    researching on Bing for something else, Anyhow I am here now and would
    just like to say many thanks for a incredible post and a all round interesting blog (I also love
    the theme/design), I don’t have time to look over it all at the moment but I have book-marked
    it and also included your RSS feeds, so when I have
    time I will be back to read a lot more, Please do keep up the fantastic b.

  10. He freely admits to experiencing difficult relationships with his
    mother and father and with his ex-wives. This is pretty much due to a gene abnormality where the white
    blood cells grow out of control and take over where
    the red blood cells are dormant. This industry has become an economic and environmentally-friendly alternative to unsustainable harvesting of hearts of palm, logging and conversion of the
    rain forest to farming or ranching.